Ohizumi Y - Search Results

1

Dual regulation of the skeletal muscle ryanodine receptor by triadin and calsequestrin.

Ohkura M, Furukawa K, Fujimori H, Kuruma A, Kawano S, Hiraoka M, Kuniyasu A, Nakayama H, Ohizumi Y. Ohkura M, et al. Among authors: ohizumi y. Biochemistry. 1998 Sep 15;37(37):12987-93. doi: 10.1021/bi972803d. Biochemistry. 1998. PMID: 9737879

2

Xestoquinone activates skeletal muscle actomyosin ATPase by modification of the specific sulfhydryl group in the myosin head probably distinct from sulfhydryl groups SH1 and SH2.

Sakamoto H, Furukawa K, Matsunaga K, Nakamura H, Ohizumi Y. Sakamoto H, et al. Among authors: ohizumi y. Biochemistry. 1995 Oct 3;34(39):12570-5. doi: 10.1021/bi00039a011. Biochemistry. 1995. PMID: 7548005

3

The properties of specific binding site of 125I-radioiodinated myotoxin a, a novel Ca++ releasing agent, in skeletal muscle sarcoplasmic reticulum.

Ohkura M, Furukawa K, Oikawa K, Ohizumi Y. Ohkura M, et al. Among authors: ohizumi y. J Pharmacol Exp Ther. 1995 May;273(2):934-9. J Pharmacol Exp Ther. 1995. PMID: 7752098

4

Calsequestrin is a major binding protein of myotoxin alpha and an endogenous Ca2+ releaser in sarcoplasmic reticulum.

Ohkura M, Furukawa K, Tu AT, Ohizumi Y. Ohkura M, et al. Among authors: ohizumi y. Eur J Pharmacol. 1994 Jun 15;268(1):R1-2. doi: 10.1016/0922-4106(94)90126-0. Eur J Pharmacol. 1994. PMID: 7925605

5

Calsequestrin is essential for the Ca2+ release induced by myotoxin alpha in skeletal muscle sarcoplasmic reticulum.

Ohkura M, Ide T, Furukawa K, Kawasaki T, Kasai M, Ohizumi Y. Ohkura M, et al. Among authors: ohizumi y. Can J Physiol Pharmacol. 1995 Aug;73(8):1181-5. doi: 10.1139/y95-167. Can J Physiol Pharmacol. 1995. PMID: 8564886

6

A new scorpion toxin (BmK-PL) stimulates Ca2+-release channel activity of the skeletal-muscle ryanodine receptor by an indirect mechanism.

Kuniyasu A, Kawano S, Hirayama Y, Ji YH, Xu K, Ohkura M, Furukawa K, Ohizumi Y, Hiraoka M, Nakayama H. Kuniyasu A, et al. Among authors: ohizumi y. Biochem J. 1999 Apr 15;339 ( Pt 2)(Pt 2):343-50. Biochem J. 1999. PMID: 10191265 Free PMC article.

7

4,6-Dibromo-3-hydroxycarbazole (an analogue of caffeine-like Ca2+ releaser), a novel type of inhibitor of Ca(2+)-induced Ca2+ release in skeletal muscle sarcoplasmic reticulum.

Takahashi Y, Furukawa K, Kozutsumi D, Ishibashi M, Kobayashi J, Ohizumi Y. Takahashi Y, et al. Among authors: ohizumi y. Br J Pharmacol. 1995 Mar;114(5):941-8. doi: 10.1111/j.1476-5381.1995.tb13295.x. Br J Pharmacol. 1995. PMID: 7540095 Free PMC article.

8

[3H]9-Methyl-7-bromoeudistomin D, a caffeine-like powerful Ca2+ releaser, binds to caffeine-binding sites distinct from the ryanodine receptors in brain microsomes.

Yoshikawa K, Furukawa K, Yamamoto M, Momose K, Ohizumi Y. Yoshikawa K, et al. Among authors: ohizumi y. FEBS Lett. 1995 Oct 16;373(3):250-4. doi: 10.1016/0014-5793(95)01021-6. FEBS Lett. 1995. PMID: 7589476 Free article.

9

Structure-activity relationship of bromoeudistomin D, a powerful Ca2+ releaser in skeletal muscle sarcoplasmic reticulum.

Takahashi Y, Furukawa K, Ishibashi M, Kozutsumi D, Ishiyama H, Kobayashi J, Ohizumi Y. Takahashi Y, et al. Among authors: ohizumi y. Eur J Pharmacol. 1995 Feb 15;288(3):285-93. doi: 10.1016/0922-4106(95)90040-3. Eur J Pharmacol. 1995. PMID: 7774672

10

Ca2+ release induced by myotoxin alpha, a radio-labellable probe having novel Ca2+ release properties in sarcoplasmic reticulum.

Furukawa K, Funayama K, Ohkura M, Oshima Y, Tu AT, Ohizumi Y. Furukawa K, et al. Among authors: ohizumi y. Br J Pharmacol. 1994 Sep;113(1):233-9. doi: 10.1111/j.1476-5381.1994.tb16199.x. Br J Pharmacol. 1994. PMID: 7812616 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

421 results

Search Page

Filters